Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126193642 | 12619364 | 2 | F | 20160721 | 20160803 | 20160818 | EXP | US-009507513-1608USA001590 | MERCK | 0.00 | Y | 0.00000 | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126193642 | 12619364 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | 12675 | TABLET | |||||||||||
| 126193642 | 12619364 | 2 | SS | DOXORUBICIN | DOXORUBICIN | 1 | 0 | ||||||||||||
| 126193642 | 12619364 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | 0 | |||||||||||
| 126193642 | 12619364 | 4 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126193642 | 12619364 | 1 | Acute lymphocytic leukaemia |
| 126193642 | 12619364 | 2 | Acute lymphocytic leukaemia |
| 126193642 | 12619364 | 3 | Acute lymphocytic leukaemia |
| 126193642 | 12619364 | 4 | Acute lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126193642 | 12619364 | DE |
| 126193642 | 12619364 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126193642 | 12619364 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |